Intravitreal triamcinolone for the management of macular edema due to branch vein occlusion

ABSTRACT

To evaluate the efficacy of intravitreal triamcinolone acetonide in the management of persistent macular edema secondary to branch vein occlusion. 10 consecutive patient were selected with 3 - to 4 month history and persistent macular edema. These patients received a single intravitreal injection of 4 mg of triamcinolone acetonide [40 mg/ml]. The control group including 12 patients did not receive an intravitreal iunjection. The mean follow-up was 8-12 months. A single intravitreal injection of triamcinolone showed significant improvement in the visual acuity [P=0.005], with clinical and angiographic resolution of macular edema in 6 patients [60%] of the 10 patients in the treated group, while only 4 [33.3%] of the 12 patients in the observation group. A single intravitreal injection of triamcinolone acetonide can increased in terms of visual acuity and macular edema for non-ischemic branch vein occlusion